Correction to Lancet Respir Med 2025; 13: 318-26
- PMID: 40180522
- PMCID: PMC12045338
- DOI: 10.1016/S2213-2600(25)00078-5
Correction to Lancet Respir Med 2025; 13: 318-26
Erratum for
-
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial.Lancet Respir Med. 2025 Apr;13(4):318-326. doi: 10.1016/S2213-2600(24)00368-0. Epub 2025 Jan 21. Lancet Respir Med. 2025. PMID: 39855244 Clinical Trial.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources